在急性中风患者的神经保护中的甘氨酸抗剂:GAIN美洲:随机对照试验
R L Sacco1, J T DeRosa, E C Haley
1The Neurological Institute, Columbia University, 710 W 168th St, Room 547, New York, NY 10032, USA. rls1@columbia.edu
JAMA
|April 13, 2001
概括
对急性缺血性中风的神经保护药物Gavestinel在6小时内治疗的患者中没有改善功能结果. 这项研究发现,与安慰剂相比,恢复或生存没有显著的益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
- 临床神经学 临床神经学
背景情况:
- 神经保护药物的开发旨在减轻缺血性中风后的脑损伤.
- 尽管对缺血级联进行了研究,但迄今为止还没有任何神经保护药物证明其临床疗效.
研究的目的:
- 为了评估加维斯丁尼尔的有效性,一个N-甲基-D-酸盐受体甘氨酸位点抗剂,作为急性缺血性中风的神经保护疗法.
- 该研究评估了在症状出现后6小时内服用gavestinel的疗效.
主要方法:
- 一项随机,双盲,安慰剂对照试验 (GAIN美洲) 涉及1367名在132个中心的缺血性中风患者.
- 患者接受了三天内静脉注射的gavestinel或安慰剂,在三个月后使用巴特尔指数评估功能结果.
- 分层包括年龄和最初的中风严重程度 (NIH中风量表).
主要成果:
- 与安慰剂 (P =.79) 相比,在三个月内,Gavestinel治疗没有导致功能结局的统计学上显著改善.
- 实现功能独立的患者比例 (巴特尔指数95-100) 在两组之间是相似的 (39%的加韦西尼尔与37%的安慰剂).
- 没有观察到生存或二次终点的显著差异,即使在接受复合组织类型等离子体激活剂的患者中也是如此.
结论:
- 在中风后长达6小时内服用的Gavestinel在3个月后没有改善功能结果.
- 该研究得出的结论是,根据评估的终点,加维斯丁尼尔不是急性缺血性中风的有效神经保护疗法.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Ischemic Stroke l: Introduction
53
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Ischemic Stroke ll: Pathophysiology
68
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
Hemorrhagic Stroke l: Introduction
34
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
34


